1/4

Export Ready

SYMIK-625

Name: SYMIK-625
SKU: 8451651
Price: 2.32 USD
Availability: InStock

Sold by Symphyra Healthcare · Retailer, Exporter, Wholesaler, Startup · Ahmedabad, Gujarat, India

Price

₹ 2.32 /Centimetre

In stock

Inclusive of all taxes

Minimum order: 1 Centimetre

Export Snapshot

MOQ

1 Centimetre

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

30049099

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for Symphyra Healthcare.

Compliance & Certifications

Suitable for

Importers · Distributors · Wholesalers

Ahmedabad Dispatch on request Verified seller

Symphyra Healthcare

Retailer, Exporter, Wholesaler, Startup · Ahmedabad, Gujarat, India

Symphyra Healthcare is a forward-thinking pharmaceutical company committed to delivering superior healthcare solutions. Founded by Dr. Rajat Thumar and Dr. Manish Vaghela, experienced professionals in the healthcare industry, Symphyra aims to enhance patient well-being through high-quality and affordable pharmaceutical products. With a strong mission to provide better healthcare through innovative products, Symphyra envisions becoming a global leader in the pharmaceutical sector. The company thrives on continuous improvement, adaptability, and a customer-centric approach, ensuring that medical professionals, hospitals, and pharmacies receive the best solutions for their needs. At Symphyra, quality, affordability, and innovation drive every aspect of business, making "Your Health is Our Priority" more than just a tagline—it’s a promise.

Registered address: Ahmedabad, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

View profile All products

Established

2023

Employees

1–10

GST

24AFDFS1182F1Z8

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Jan 2025

Turnover

100000 - 2500000.

Incorporation Type

On request

Verified Seller

Product details

What are the specifications of this product?

Overview

SYMIK-625 Amoxicillin Trihydrate IP 500 mg + Potassium Clavulanate Diluted IP 125 mg SYMIK-625 combines Amoxicillin, a penicillin-based antibiotic, with Potassium Clavulanate, which helps protect Amoxicillin from being broken down by bacteria. This powerful duo allows Amoxicillin to work effectively against a wider range of bacteria, including those that have developed resistance to Amoxicillin alone. SYMIK-625 is commonly used to treat infections in the ears, sinuses, lungs, skin, urinary tract, and teeth.

Product Description

SYMIK-625 is an effective combination antibiotic designed to combat bacterial infections. Amoxicillin works by attacking bacterial cell walls, while Potassium Clavulanate prevents bacteria from breaking down Amoxicillin, making it more effective against resistant strains. This combination helps fight infections in various areas, including the respiratory tract, urinary tract, skin, ears, and dental infections. SYMIK-625 provides a reliable solution for a broad spectrum of bacterial infections, ensuring fast and effective treatment.

Description provided by Symphyra Healthcare.

Specifications

Chemical Composition	Amoxicillin Trihydrate 500 mg, Potassium Clavulanate 125 mg
Dosage Form	Tablets
Strength	625 mg per tablet
Indications	Bacterial infections of the ears, lungs, urinary tract, skin and teeth
Storage Conditions	Store in a cool, dry place away from direct sunlight
Shelf Life	24 months from the date of manufacture

Use cases

Category	healthcare > drugs and medicine > prescription medications
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Centimetre
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing SYMIK-625. Answers compiled from verified sellers' commercial terms and platform data.

Q: What are the primary infections treated by SYMIK-625?

A: SYMIK-625 is effective in treating infections in the ears, sinuses, lungs, skin, urinary tract, and dental infections.

Q: How does Potassium Clavulanate enhance the effectiveness of Amoxicillin?

A: Potassium Clavulanate protects Amoxicillin from being broken down by beta-lactamase-producing bacteria, allowing Amoxicillin to act effectively against a wider range of resistant bacterial strains.

Q: What is the recommended dosage of SYMIK-625?

A: The recommended dosage depends on the specific infection and patient condition; however, it typically adheres to medical guidelines for Amoxicillin and Clavulanate combinations.

Question not answered? Ask sellers directly — typical response within 4 hours.